Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci
about
Topical triple-antibiotic ointment as a novel therapeutic choice in wound management and infection prevention: a practical perspectivePleuromutilins: use in food-producing animals in the European Union, development of resistance and impact on human and animal healthInduced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivityA New Combination of a Pleuromutilin Derivative and Doxycycline for Treatment of Multidrug-Resistant Acinetobacter baumannii.Update on topical antibiotics in dermatology.Retapamulin inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells.Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children.Cutaneous infections and infestations: new therapiesPrevention of Recurrent Staphylococcal Skin InfectionsDecolonization in Prevention of Health Care-Associated Infections.Agents for the decolonization of methicillin-resistant Staphylococcus aureus.Microbiological profile of a new topical antibacterial: retapamulin ointment 1%.The good, the bad and the tasty: The many roles of mushrooms.Bacterial resistance and impetigo treatment trends: a review.In Vitro Activity of Retapamulin and Antimicrobial Susceptibility Patterns in a Longitudinal Collection of Methicillin-Resistant Staphylococcus aureus Isolates from a Veterans Affairs Medical Center.Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741.Antimicrobial Peptide P60.4Ac-Containing Creams and Gel for Eradication of Methicillin-Resistant Staphylococcus aureus from Cultured Skin and Airway Epithelial Surfaces.Topical retapamulin in the management of infected traumatic skin lesions.Investigation of the potential for mutational resistance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage studyLinezolid and tiamulin cross-resistance in Staphylococcus aureus mediated by point mutations in the peptidyl transferase center.Proposed MIC and disk diffusion microbiological cutoffs and spectrum of activity of retapamulin, a novel topical antimicrobial agent.Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial.Biosynthetic Machinery of Diterpene Pleuromutilin Isolated from Basidiomycete Fungi.Antimicrobial potential of Australian macrofungi extracts against foodborne and other pathogens.Evaluation of antibacterial activity of Australian basidiomycetous macrofungi using a high-throughput 96-well plate assay.An antimycobacterial pleuromutilin analogue effective against dormant bacilli
P2860
Q22305939-7EE581DF-F56A-46A9-BA4A-370B77ED9313Q27015971-019A979D-64CC-4648-BAF7-544C466D1AF5Q27644059-FFD50BF2-C04D-425F-A7F6-65CAF83E357EQ33792789-5A7B3AB3-46A8-43C8-90FF-87332AA37BE0Q34275347-9CACBCF3-79C3-470A-9732-CA8CEF58CF22Q34580239-825E8492-BF86-4F0A-860D-E3BE3080E8FBQ34585413-75DF4312-C8BC-4651-A70E-D1F1D77B3323Q35628618-60FC2F9D-CE08-40C6-A579-EE5E2A1A0884Q36005464-121AE13F-1DD5-41C5-AFCD-FAC358330600Q36675240-D5B5DC90-96E0-49D8-AE47-3FE43360D74AQ37403450-3FD54579-4105-4776-BCE7-B68BABFA6723Q37432080-248E9B0D-CC1F-4374-A91F-EB42D81E59B6Q37570744-E38D9C6C-243B-4FAE-B86B-D76650E5A13BQ37980796-880AFD34-A50B-403F-BD63-995EA81504B9Q38741373-3654B4E0-C28E-4AFE-886E-838ACE8D0D19Q40202934-2BC571EF-9885-4396-8800-4A3F3FF8A543Q40699469-EA8BA138-377E-4E0E-8965-457800BB3BBDQ41435804-53503411-144D-4E2D-A688-49FA480F7016Q42009908-EADB46E2-560E-4062-888E-96E2398ED34EQ43183363-07E2371A-2FEA-4EDB-A58C-158BDEBBA2C4Q43251094-169D9156-B684-4215-9A05-139F58E87B28Q46701427-58884E94-7C12-4CE7-8CF4-DE50BA1DCE76Q47780684-8DF03342-0B5E-4684-BEAF-9298D0429E19Q54357635-E87A9533-C22D-41F0-A432-EF22C051D985Q54369438-5987B5DB-A897-4FE4-98F2-1D0B2FEEA074Q58766556-8532D8A7-DC23-43F4-B7CF-4FE688018601
P2860
Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Activity of retapamulin (SB-27 ...... resistant gram-positive cocci
@ast
Activity of retapamulin (SB-27 ...... resistant gram-positive cocci
@en
Activity of retapamulin (SB-27 ...... resistant gram-positive cocci
@nl
type
label
Activity of retapamulin (SB-27 ...... resistant gram-positive cocci
@ast
Activity of retapamulin (SB-27 ...... resistant gram-positive cocci
@en
Activity of retapamulin (SB-27 ...... resistant gram-positive cocci
@nl
prefLabel
Activity of retapamulin (SB-27 ...... resistant gram-positive cocci
@ast
Activity of retapamulin (SB-27 ...... resistant gram-positive cocci
@en
Activity of retapamulin (SB-27 ...... resistant gram-positive cocci
@nl
P2093
P2860
P356
P1476
Activity of retapamulin (SB-27 ...... resistant gram-positive cocci
@en
P2093
James E Ross
Ronald N Jones
Thomas R Fritsche
P2860
P304
P356
10.1128/AAC.01432-05
P407
P577
2006-07-01T00:00:00Z